Allison M. Martin
Newton, MA ****8
****************@*****.***
Summary
Experienced biologist in the medical field with an extensive background in SOPs and clinical research. Self motivated, detail-oriented, and capable of multitasking in the absence of supervision. Adept at a wide variety of computer and research skills.
Professional Experience
DANA-FARBER CANCER INSTITUTE / HARVARD MEDICAL SCHOOL - Boston, MA
Department of Medical Oncology; Division of Hematological Malignances
Lead Research Technician 10/11 to 08/12
. Independently researched new experimental instructions and implemented
solutions in order to overcome barriers.
. Acted as a representative for the lab during various trade shows with
vendors and suppliers.
. Trained, educated, and mentored Post-Doctoral student and summer interns
in experimental procedures, analysis and interpretation of data, the use
of various equipment, and time management.
. Purchased equipment, chemicals, biological specimens and consumables for
the laboratory, and maintained appropriate inventory levels.
. Communicated with outside sales vendors to negotiate pricing and receive
updates concerning new inventory.
. Maintained accurate records of all laboratory procedures, reagents,
upcoming tasks, etc.
. Computer skills: Microsoft Office (PowerPoint, Excel, Access, Word),
Oracle, Flow cytometry (FACS), FCAP Array, FlowJo, Peoplesoft, iLabs,
etc.
. Expanded on and mastered a growing list of aseptic techniques used daily
in the laboratory including: apoptosis experiments (Calcein, Annexin,
etc), human primary cells (Ficoll, NK isolation, etc), Immunoassay
experiments (Cytometric Bead Array, ELISA, Western blot, etc), qPCR,
lenti-viral experiments (create shRNA, siRNA transfection, etc), cell
tissue culture (knock down lines produced), recombinant DNA experiments
(Mini Preps, Maxi Preps), and staining experiments (intracellular and
surface).
Senior Research Technician 5/09 to 9/11
. Worked in a collaborative environment; taught summer interns basic
laboratory skills, supervised their activities, and explained how to
interpret and analyze their experimental findings.
. Used lentiviruses to inject Myeloma cells with shRNA to knock down genes
and analyzed how these genes affect susceptibility to NK cells.
Research Technician 9/07 - 4/09
. Used robotic equipment and performed high through-put screen (HTS), in
order to identify new pathways involved in the sensitivity of tumor
cells.
. Created effective Excel spreadsheet to compare and exemplify top and
bottom 10% of genes found in large scale genetic screening.
Summer Research Technician 6/07 - 8/07
. Quickly learned how to maintain cell culture, produced protein lysates,
created shRNA, extracted DNA from bacteria, and cytokine ELISA analysis.
. Efficiently stained cells with various antibodies and read on FACS.
WALT DISNEY WORLD- Orlando, FL
Bay Lake Region Deep Water Lifeguard and First Aid Intern 5/06- 8/06
. Gained leadership, teamwork, and customer service ability by working with
guests.
Education
NORTHERN ILLINOIS UNIVERSITY - DeKalb, IL
Bachelor of Sciences from the College of Biological Sciences, 2007
Biology Major, Chemistry Minor
Biological Sciences Honors Society
Publications
ORIGINAL ARTICLES
Bellucci R, Nguyen H, Martin A, Schinzel A, Hahn W and Ritz, J. Multiple
Tyrosine Kinase Pathways Modulate Tumor Susceptibility to Human Natural
Killer cells. Journal of Clinical Investigation. Accepted June 2012.
ABSTRACTS & POSTERS
. Bellucci R, Nguyen H, Martin A, Heinrichs S, Schinzel A, Daley J, Hansen
S, Hahn W and Ritz, J. Genetic Screening for Myeloma Cell Susceptibility
to NK cell Mediated Lysis Using Large Lentiviral shRNA Libraries. Blood.
2008; 112:997-998. 50th ASH Annual Meeting and Exposition; San Francisco,
California
. Bellucci R, Nguyen H, Martin A, Schinzel A, Heinrichs S, Hahn W and Ritz,
J. Novel Pathways Modulate TUMOR CELL Susceptibility to NK CELLS. Blood.
2009;114:117-118. 51th ASH Annual Meeting and Exposition; New Orleans, LA
. Buren M, Martin A, Ritz J, Bellucci R. Analysis of the STAT Signaling
Pathway in JAK-1 and JAK-2 KO Multiple Myeloma Cells. Oct 2010. Albany
Medical College Presentation; Albany, NY.
. Bellucci R, Martin A, Nguyen H, Schinzel A, Hahn W and Ritz, J. Multiple
Tyrosine Kinase Pathways Modulate Myeloma (MM) Cell Susceptibility to
Human Natural Killer (NK) Cells. Haematologica. 2011; 97: S57; 13th
International Myeloma Workshop; Paris, France.
. Bellucci R, Martin A, Buren M, Nguyen H, Bommarito D and Ritz J. JAK1 and
JAK2 Modulate Myeloma Cell Susceptibilty to NK Cells Through the
Interferon-gamma (IFN-y) Pathway. Blood 2011 In Press; 53 rd ASH Annual
Meeting and Exposition; San Diego, CA
. McKenzie G, Bommarito D, Martin, A, Ritz, J and Bellucci, R. PIK3CB
Knockdown in Myeloma Cell Lines May Increase Tumor Susceptibility to
Natural Killer (NK) Cells. Annual presentation of the 2011 CURE Mentor
Program; Boston, MA.
References
Available upon request